Corneal application of SOCS1/3 peptides for the treatment of eye diseases mediated by inflammation and oxidative stress
Several blinding diseases affecting the retina and optic nerve are exacerbated by or caused by dysregulated inflammation and oxidative stress. These diseases include uveitis, age related macular degeneration, diabetic retinopathy and glaucoma. Conseque…